Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
58M
-
Shares change
-
-2.33M
-
Total reported value, excl. options
-
$2.01B
-
Value change
-
-$90.1M
-
Put/Call ratio
-
0.64
-
Number of buys
-
108
-
Number of sells
-
-78
-
Price
-
$34.96
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q2 2022
234 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q2 2022.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58M shares
of 60.4M outstanding shares and own 96.03% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (6.27M shares), BlackRock Inc. (4.97M shares), VANGUARD GROUP INC (4.93M shares), STATE STREET CORP (3.82M shares), FMR LLC (3.57M shares), JPMORGAN CHASE & CO (3.2M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.72M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.68M shares), Nikko Asset Management Americas, Inc. (2.68M shares), and Jackson Square Partners, LLC (2.5M shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.